# The Effects of Semaglutide vs Testosterone Replacement Therapy on Functional Hypogonadism and Sperm Quality in Men With Type 2 Diabetes Mellitus and Obesity

> **NCT06489457** · PHASE3 · COMPLETED · sponsor: **University Medical Centre Ljubljana** · enrollment: 25 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus
- Obesity
- Functional Hypogonadism

## Interventions

- **DRUG:** Semaglutide
- **DRUG:** Testosterone Undecanoate

## Key facts

- **NCT ID:** NCT06489457
- **Lead sponsor:** University Medical Centre Ljubljana
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-09-20
- **Primary completion:** 2023-05-11
- **Final completion:** 2023-06-30
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2024-07-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06489457

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06489457, "The Effects of Semaglutide vs Testosterone Replacement Therapy on Functional Hypogonadism and Sperm Quality in Men With Type 2 Diabetes Mellitus and Obesity". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06489457. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*